Goodman M G, Chenoweth D E, Weigle W O
J Exp Med. 1982 Sep 1;156(3):912-7. doi: 10.1084/jem.156.3.912.
The mechanism by which human C5a anaphylatoxin augments the primary humoral response of murine splenocytes to antigen has been investigated. Culture supernatants were generated from splenic adherent cells or macrophage cell lines after exposure to a brief pulse of human C5a. Supernatants from the macrophage-like cell line P388D1, which bears surface receptors for C5a, enhance the PFC response to antigen, whereas those from the closely related cell line P388, which lacks surface receptors for C5a, fail to cause enhancement. Supernatants from splenic adherent cells, which also bear C5a receptors, similarly augment the SRBC response. Active supernatants, but not those devoid of activity, were shown to contain interleukin 1 (IL-1) activity by both the thymocyte mitogenesis and thymocyte costimulator assays. None of the supernatants contained IL-2 activity. These observations suggest that the recently described role of human C5a as an immunopotentiating modulator is mediated by its ability to induce production of IL-1 upon binding to specific receptors at the macrophage cell surface.
人类C5a过敏毒素增强小鼠脾细胞对抗原的初次体液免疫反应的机制已得到研究。将人类C5a短暂脉冲处理后,从脾黏附细胞或巨噬细胞系中获得培养上清液。巨噬细胞样细胞系P388D1(其表面带有C5a受体)的上清液可增强对抗原的PFC反应,而与之密切相关的细胞系P388(缺乏C5a表面受体)的上清液则不能引起增强作用。同样带有C5a受体的脾黏附细胞的上清液也能增强对SRBC的反应。通过胸腺细胞有丝分裂和胸腺细胞共刺激试验表明,有活性的上清液含有白细胞介素1(IL-1)活性,而无活性的上清液则不含IL-1活性。所有上清液均不含IL-2活性。这些观察结果表明,最近所描述的人类C5a作为免疫增强调节剂的作用是通过其与巨噬细胞表面特异性受体结合后诱导IL-1产生的能力介导的。